Literature DB >> 22038848

Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis.

Alexandre S de Almeida1, Christina T Fiske, Timothy R Sterling, Spyros A Kalams.   

Abstract

Extrapulmonary tuberculosis may be due to underlying immune compromise. Immunosuppressive regulatory T cells (Treg cells), and CD4(+) T lymphocytes in general, are important in the host immune response to Mycobacterium tuberculosis. We evaluated T lymphocytes from patients after recovery from extrapulmonary tuberculosis, which may reflect conditions before M. tuberculosis infection. A case-control study was conducted among HIV-uninfected adults with previously treated extrapulmonary tuberculosis and 3 sets of controls: (i) subjects with previously treated pulmonary tuberculosis, (ii) close tuberculosis contacts with M. tuberculosis infection, and (iii) close tuberculosis contacts with no infection. Monocyte-depleted peripheral blood mononuclear cells (PBMC-M) were stained for CD4(+) CD25(hi) CD127(low) FoxP3(+) cell (Treg cell) and T lymphocyte activation. Both characteristics were compared as continuous variables between groups with the Kruskal-Wallis test. There were 7 extrapulmonary tuberculosis cases, 18 pulmonary tuberculosis controls, 17 controls with M. tuberculosis infection, and 18 controls without M. tuberculosis infection. The median Treg cell proportion was highest among persons with previous extrapulmonary tuberculosis (1.23%) compared to subjects with pulmonary tuberculosis (0.56%), latent M. tuberculosis infection (0.14%), or no M. tuberculosis infection (0.20%) (P = 0.001). The median proportion of CD4(+) T lymphocytes that expressed the activation markers HLA-DR and CD38 was highest for CD4(+) T lymphocytes from persons with previous extrapulmonary tuberculosis (0.79%) compared to subjects with pulmonary tuberculosis (0.44%), latent M. tuberculosis infection (0.14%), or no M. tuberculosis infection (0.32%) (P = 0.005). Compared with controls, persons with previously treated extrapulmonary tuberculosis had the highest Treg cell frequency, but also the highest levels of CD4(+) T lymphocyte activation. Immune dysregulation may be a feature of individuals at risk for extrapulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038848      PMCID: PMC3255960          DOI: 10.1128/CVI.05263-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  56 in total

1.  Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.

Authors:  Peter Klucar; Peter F Barnes; Ying Kong; Buka Samten; Amy Tvinnereim; Ralf Spallek; Gerald T Nepom; Mahavir Singh; Homayoun Shams
Journal:  Hum Immunol       Date:  2008-06-25       Impact factor: 2.850

2.  Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.

Authors:  Rui Wang; Lina Kozhaya; Frances Mercer; Alka Khaitan; Hodaka Fujii; Derya Unutmaz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

3.  Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment.

Authors:  Warly Barcelos; Olindo Assis Martins-Filho; Tânia Mara Pinto Dabés Guimarães; Márcio Hamilton Prostzner Oliveira; Silvana Spíndola-de-Miranda; Beatriz Nascimento Carvalho; Vicente de Paulo Coelho Peixoto de Toledo
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

4.  CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.

Authors:  Xinchun Chen; Boping Zhou; Meizhong Li; Qunyi Deng; Xueqiong Wu; Xiaohua Le; Chi Wu; Nicolas Larmonier; Wei Zhang; Hongmei Zhang; Huosheng Wang; Emmanuel Katsanis
Journal:  Clin Immunol       Date:  2007-01-17       Impact factor: 3.969

5.  FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.

Authors:  Lishomwa C Ndhlovu; Christopher P Loo; Gerald Spotts; Douglas F Nixon; Frederick M Hecht
Journal:  J Leukoc Biol       Date:  2007-11-02       Impact factor: 4.962

6.  Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.

Authors:  Joel Fleury Djoba Siawaya; Novel N Chegou; Michel M van den Heuvel; Andreas H Diacon; Nulda Beyers; Paul van Helden; Gerhard Walzl
Journal:  Cytokine       Date:  2009-06-30       Impact factor: 3.861

7.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.

Authors:  Dat Q Tran; John Andersson; Rui Wang; Heather Ramsey; Derya Unutmaz; Ethan M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

9.  FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis.

Authors:  Prabhat K Sharma; Pradip K Saha; Amar Singh; Surendra K Sharma; Balaram Ghosh; Dipendra K Mitra
Journal:  Am J Respir Crit Care Med       Date:  2009-02-26       Impact factor: 21.405

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  23 in total

1.  Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.

Authors:  Caian L Vinhaes; Deivide Oliveira-de-Souza; Paulo S Silveira-Mattos; Betania Nogueira; Ruiru Shi; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Clifton E Barry; Laura E Via; Kiyoshi F Fukutani; Bruno B Andrade; Katrin D Mayer-Barber
Journal:  Cytokine       Date:  2019-06-18       Impact factor: 3.861

2.  Site of extrapulmonary tuberculosis is associated with HIV infection.

Authors:  Ira L Leeds; Matthew J Magee; Ekaterina V Kurbatova; Carlos del Rio; Henry M Blumberg; Michael K Leonard; Colleen S Kraft
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

3.  Pathogenesis and immune response in tuberculous meningitis.

Authors:  Bini Estela Isabel; Hernández Pando Rogelio
Journal:  Malays J Med Sci       Date:  2014-01

4.  Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Authors:  M A Huaman; C T Fiske; T F Jones; J Warkentin; B E Shepherd; L A Ingram; F Maruri; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

5.  Effect of TGF-β1 on blood CD4+CD25high regulatory T cell proliferation and Foxp3 expression during non-small cell lung cancer blood metastasis.

Authors:  Yi Hu; Weibo Qi; Li Sun; Hui Zhou; Biliu Zhou; Zhiping Yang
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

6.  Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.

Authors:  Christina T Fiske; Alexandre S de Almeida; Ayumi K Shintani; Spyros A Kalams; Timothy R Sterling
Journal:  Clin Vaccine Immunol       Date:  2012-06-06

7.  The role of T regulatory cell-associated markers in monitoring tuberculosis treatment completion and failure.

Authors:  Sonali Agrawal; Om Parkash; Alangudi Natarajan Palaniappan; Ashok K Bhatia; Santosh Kumar; Devendra S Chauhan; M Madhan Kumar
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

8.  25-Hydroxyvitamin D levels after recovery from tuberculosis: insights into pathogenesis.

Authors:  Moises A Huaman; Timothy R Sterling; Bryan E Shepherd; Christina T Fiske
Journal:  Tuberculosis (Edinb)       Date:  2013-11-06       Impact factor: 3.131

9.  Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV.

Authors:  Zuri A Sullivan; Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz; William R Bishai
Journal:  EBioMedicine       Date:  2015-04-01       Impact factor: 8.143

10.  Asymptomatic Helminth Infection in Active Tuberculosis Is Associated with Increased Regulatory and Th-2 Responses and a Lower Sputum Smear Positivity.

Authors:  Ebba Abate; Meseret Belayneh; Jonna Idh; Ermias Diro; Daniel Elias; Sven Britton; Abraham Aseffa; Olle Stendahl; Thomas Schön
Journal:  PLoS Negl Trop Dis       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.